EDAP to Present at the Piper Sandler 34th Annual Healthcare Conference
21 nov. 2022 08h00 HE
|
EDAP TMS S.A.
LYON, France, November 21, 2022 -- EDAP TMS SA (Nasdaq: EDAP) (the “Company”), a global leader in robotic energy-based therapies, announced today that Marc Oczachowski, Chief Executive Officer, is...
EDAP Reports Third Quarter 2022 Results
16 nov. 2022 16h35 HE
|
EDAP TMS S.A.
Generated Q3 2022 total revenue of approximately EUR 12.2 million (USD 12.3 million), an increase of 29.7 % as compared to EUR 9.4 million (USD 11.1 million) for Q3 2021; nine-month year-to-date...
EDAP TMS SA to Announce Third Quarter 2022 Financial Results on Wednesday, November 16th, 2022
02 nov. 2022 08h00 HE
|
EDAP TMS S.A.
Company to host conference call and webcast on Thursday, November 17th at 8:30 am EDT LYON, France, November 2, 2022 - EDAP TMS SA (Nasdaq: EDAP), the global leader in robotic energy-based therapies,...
EDAP Announces Focal One® HIFU Reimbursement Raised to Urology APC Level 6 Under CMS Outpatient Prospective Payment System (OPPS) Final Rule for CY23
01 nov. 2022 17h22 HE
|
EDAP TMS S.A.
Final rule significantly raises Medicare reimbursement to U.S. hospitals performing a Focal One HIFU prostate ablation procedure LYON, France, November 1, 2022 -- EDAP TMS SA (Nasdaq: EDAP) (“the...
EDAP TMS Hosting Urology Expert Panel and Live Focal One® Technology Demonstration
26 sept. 2022 08h00 HE
|
EDAP TMS S.A.
September 29, 2022 @ 8 AM ETLangham Hotel, NYC LYON, France, September 26, 2022 -- EDAP TMS SA (Nasdaq: EDAP) (the “Company”), the global leader in robotic therapeutic ultrasound, announced today it...
EDAP Announces Pricing of Public Offering of American Depositary Shares
22 sept. 2022 20h54 HE
|
EDAP TMS S.A.
LYON, France, September 22, 2022 -- EDAP TMS S.A. (NASDAQ: EDAP) (the “Company”), a global leader in robotic energy-based therapies, announced that the price of its public offering of its American...
EDAP Announces Proposed Public Offering of American Depositary Shares
22 sept. 2022 16h01 HE
|
EDAP TMS S.A.
LYON, France, September 22, 2022 -- EDAP TMS S.A. (NASDAQ: EDAP) (the “Company”), a global leader in robotic energy-based therapies, announced today that it has commenced a public offering of its...
EDAP Reports Second Quarter 2022 Results
24 août 2022 16h35 HE
|
EDAP TMS S.A.
Announced Focal One® HIFU reimbursement raised to urology APC Level 6 under CMS Outpatient Prospective Payment System (OPPS) proposed rule for CY23Second quarter 2022 total revenue of approximately...
EDAP TMS SA to Announce Second Quarter 2022 Financial Results on August 24th, 2022
03 août 2022 08h00 HE
|
EDAP TMS S.A.
Company to host conference call and webcast on Thursday, August 25th at 8:30 am EDT LYON, France, August 3, 2022 - EDAP TMS SA (Nasdaq: EDAP), the global leader in robotic energy-based therapies,...
EDAP Announces Focal One® HIFU Reimbursement Raised to Urology APC Level 6 Under CMS Outpatient Prospective Payment System (OPPS) Proposed Rule for CY23
18 juil. 2022 07h00 HE
|
EDAP TMS S.A.
Proposed rule, if adopted for CY23, would increase Medicare Payment for a Focal One HIFU procedure completed on an outpatient basis at a hospital LYON, France, July 18, 2022 -- EDAP TMS SA (Nasdaq:...